SHILPAMED
₹315.90 (0%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net profit increased to ₹31.78 crore in 202412, showcasing robust profitability growth from prior quarters.
- Operating margin improved to 12.57%, indicating better cost control and efficiency measures.
- Consistent sales growth observed, with ₹319.32 crore in the latest quarter, signaling strong market demand.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 291.69 | 292.51 | 343.80 | 319.32 | 330.81 | 321.46 | 369.97 | 409.73 | |
| Expenses | 272.46 | 269.76 | 311.63 | 279.18 | 297.32 | 277.52 | 307.18 | 336.47 | |
| Operating Profit | 19.23 | 22.75 | 32.17 | 40.14 | 33.48 | 43.93 | 62.79 | 73.26 | |
| Other Income | 2.49 | 9.44 | 4.99 | 1.13 | 7.57 | 6.38 | 1.75 | 0.81 | |
| Interest | 24.20 | 23.74 | 25.55 | 11.75 | 14.49 | 18.78 | 15.67 | 10.68 | |
| Depreciation | 26.63 | 27.11 | 28.28 | 28.81 | 28.79 | 28.92 | 29.82 | 30.36 | |
| Profit Before Tax | 27.71 | 28.68 | 36.77 | 41.61 | 15.27 | 49.58 | 64.43 | 60.85 | |
| Tax | 3.21 | 14.62 | 18.83 | 9.83 | 0.77 | 2.69 | 20.36 | 16.27 | |
| Net Profit | 24.50 | 14.06 | 17.94 | 31.78 | 14.51 | 46.89 | 44.07 | 44.58 | |
| EPS in Rs | 2.82 | 1.46 | 1.83 | 3.25 | 1.48 | 4.79 | 2.25 | 2.36 |